Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Palbociclib | 0.031623 | uM | 4 | 156.25 | 44.67 | 73.00 | 60.50 | 1.2066 | 2.0716 |
| BT-20 | Taxol | 1 | uM | 4 | 156.25 | 44.67 | 44.00 | 60.50 | 0.7273 | -0.0338 |
| BT-20 | Palbociclib | 3.1623 | uM | 4 | 156.25 | 44.67 | 46.00 | 60.50 | 0.7603 | 0.0695 |
| BT-20 | Omipalisib | 0.0033113 | uM | 4 | 156.25 | 44.67 | 42.00 | 60.50 | 0.6942 | -0.1312 |
| BT-20 | Methotrexate | 0.1 | uM | 4 | 156.25 | 44.67 | 55.00 | 60.50 | 0.9091 | 0.6087 |
| BT-20 | Omipalisib | 10 | uM | 4 | 156.25 | 44.67 | 8.00 | 60.50 | 0.1322 | -0.9803 |
| BT-20 | Methotrexate | 1 | uM | 4 | 156.25 | 44.67 | 47.00 | 60.50 | 0.7769 | 0.1234 |
| BT-20 | Methotrexate | 0.0033113 | uM | 4 | 156.25 | 44.67 | 64.00 | 60.50 | 1.0579 | 1.2742 |
| BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 44.00 | 60.50 | 0.7273 | -0.0338 | |
| BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 36.00 | 60.50 | 0.5950 | -0.3891 | |
| BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 42.00 | 60.50 | 0.6942 | -0.1312 | |
| BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 61.00 | 60.50 | 1.0083 | 1.0380 | |
| BT-20 | Taxol | 0.01 | uM | 4 | 156.25 | 44.67 | 61.00 | 60.50 | 1.0083 | 1.0380 |
| BT-20 | Taxol | 0.1 | uM | 4 | 156.25 | 44.67 | 50.00 | 60.50 | 0.8265 | 0.2939 |
| BT-20 | Methotrexate | 0.31623 | uM | 4 | 156.25 | 44.67 | 72.00 | 60.50 | 1.1901 | 1.9764 |
| BT-20 | Taxol | 0.00016596 | uM | 4 | 156.25 | 44.67 | 53.00 | 60.50 | 0.8760 | 0.4782 |
| BT-20 | Palbociclib | 19.9526 | uM | 4 | 156.25 | 44.67 | 57.00 | 60.50 | 0.9422 | 0.7455 |
| BT-20 | Omipalisib | 0.1 | uM | 4 | 156.25 | 44.67 | 31.00 | 60.50 | 0.5124 | -0.5659 |
| BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 66.00 | 60.50 | 1.0909 | 1.4398 | |
| BT-20 | Palbociclib | 1 | uM | 4 | 156.25 | 44.67 | 48.00 | 60.50 | 0.7934 | 0.1787 |
| BT-20 | Omipalisib | 3.1623 | uM | 4 | 156.25 | 44.67 | 23.00 | 60.50 | 0.3802 | -0.7805 |
| BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 84.00 | 60.50 | 1.3884 | 3.2328 | |
| BT-20 | Omipalisib | 1 | uM | 4 | 156.25 | 44.67 | 42.00 | 60.50 | 0.6942 | -0.1312 |
| BT-20 | Methotrexate | 0.0016596 | uM | 4 | 156.25 | 44.67 | 61.00 | 60.50 | 1.0083 | 1.0380 |
| BT-20 | Palbociclib | 0.01 | uM | 4 | 156.25 | 44.67 | 63.00 | 60.50 | 1.0413 | 1.1938 |